ERBB2 and breast cancer: Xiping et al. reported that MALAT1 expression was positively correlated with metastatic lymph nodes in breast cancer patients and promotes proliferation and invasion abilities through XPB1-HIF −1α and Her2 pathways in MDA-MB-231 and MDA-MD-435 breast cancer cell lines, respectively [37].